/biz/ - Business & Finance

Anonymous Tue Feb 18 07:16:44 2020 No.17309948 [View]
File: 231 KB, 895x1750, 9E3C4861-059A-4A0C-9470-7E64789137C2.jpg [View same] [iqdb] [saucenao] [google]

>>17309284
in 2015 ABBVIE paid $21B for 50% rights of Ibrutinib (which is inferior to U2 combo of TGTX in terms of efficacy and toxicity). other 50% owned by JNJ. $42B in toto fair value of Ibrutinib in 2015. TGTX market cap is $1.5B and they also have an emerging multiple sclerosis drug which is better than Roche's Ocrevus which is already registering $3.5B sales annually

Advanced search
Text to find
Subject [?]Search by post subject. Leave empty for any.
Username [?]Search for user name. Leave empty for any user name.
Tripcode [?]Search for tripcode. Leave empty for any.
Email [?]Search by email. Leave empty for any.
Filename [?]Search by image filename. Leave empty for any.
From Date [?]Enter what date to start searching from. Format is YYYY-MM-DD
To Date [?]Enter what date to start searching until. Format is YYYY-MM-DD
Image hash
Search in	All Posts OPs Only
Deleted posts	Show all posts Show only deleted posts Only show non-deleted posts
Internal posts	Show all posts Show only internal posts Show only archived posts
Order	New posts first Old posts first
Capcode	All Posts Only by Users Only by Mods Only by Admins Only by Developers
Results	Posts Threads
Action	[ Simple ]

Navigation
View posts	[+24]	[+48]	[+96]

/biz/ - Business & Finance

Search: